{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:44:18Z","timestamp":1790844258365,"version":"4.1.0"},"reference-count":29,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T00:00:00Z","timestamp":1187827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2007,10]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>We conducted a randomized placebo\u2010controlled trial to examine the effects of metformin on visceral adipose tissue (VAT), appendicular fat, lipid profile and insulin sensitivity in HIV\u2010infected persons with central adiposity and mild insulin resistance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Forty\u2010eight HIV\u2010infected men and women with a self\u2010reported increase in abdominal girth and an abnormal waist\u2010to\u2010hip ratio were randomly assigned in double\u2010blind fashion to receive metformin 1500 mg or placebo daily for 24 weeks. Persons with diabetes were excluded. The following measures were obtained at baseline and 24 weeks: single\u2010slice computed tomography (CT) scan, dual\u2010energy X\u2010ray absorptiometry (DEXA), lipid profile and oral glucose tolerance test.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The median fasting insulin concentration of all participants was 12.3 \u03bcU\/mL. The percentage change in VAT was not significantly different between the metformin and placebo groups in univariate analysis and linear regression analysis adjusting for age, height, baseline VAT and insulin area under the curve (10.1% vs 3.2%; <jats:italic>P<\/jats:italic>=0.58). Metformin was associated with a significant decrease in appendicular fat mass compared with placebo (\u2212686.0 vs 161.0 g; <jats:italic>P<\/jats:italic>=0.03). There was no significant change in lipid profile or insulin sensitivity between the two groups at 24 weeks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Metformin should be used with caution in the treatment of HIV lipodystrophy, and, if used, should be reserved for persons with adequate peripheral fat and marked insulin resistance.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1293.2007.00488.x","type":"journal-article","created":{"date-parts":[[2007,8,24]],"date-time":"2007-08-24T10:45:01Z","timestamp":1187952301000},"page":"420-426","source":"Crossref","is-referenced-by-count":61,"title":["A randomized placebo\u2010controlled trial of metformin for the treatment of HIV lipodystrophy"],"prefix":"10.1111","volume":"8","author":[{"given":"R","family":"Kohli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Shevitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Gorbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Wanke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,8,23]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199807000-00003"},{"key":"e_1_2_6_3_2","first-page":"860","article-title":"The study of fat redistribution and metabolic change in HIV infection (FRAM)","volume":"163","author":"Tien PC","year":"2006","journal-title":"methods, design, and sample characteristics"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000182230.47819.aa"},{"key":"e_1_2_6_5_2","first-page":"37","article-title":"Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy","volume":"14","author":"Saint\u2010Marc T","year":"2000","journal-title":"preliminary results of the LIPOCO study"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200107270-00008"},{"key":"e_1_2_6_7_2","first-page":"293","article-title":"HIV lipodystrophy","volume":"4","author":"Miller J","year":"2003","journal-title":"prevalence, severity and correlates of risk in Australia"},{"key":"e_1_2_6_8_2","first-page":"1662","article-title":"CD4+cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV\u2010infected adults","volume":"41","author":"McDermott AY","year":"2005","journal-title":"a longitudinal study"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1086\/430379"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199903010-00003"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803263381301"},{"key":"e_1_2_6_12_2","first-page":"395","article-title":"Redefining lipodystrophy syndrome","volume":"39","author":"Lichtenstein KA.","year":"2005","journal-title":"risks and impact on clinical decision making"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1086\/507333"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-5-200509060-00009"},{"key":"e_1_2_6_15_2","first-page":"472","article-title":"Metformin in the treatment of HIV lipodystrophy syndrome","volume":"284","author":"Hadigan C","year":"2000","journal-title":"a randomized controlled trial"},{"key":"e_1_2_6_16_2","first-page":"726","article-title":"An objective case definition of lipodystrophy in HIV\u2010infected adults","volume":"361","author":"Carr A","year":"2003","journal-title":"a case-control study"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200308150-00004"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1086\/375885"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/76.2.460"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1086\/368185"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-128-7-199804010-00002"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-110-11-867"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/317541"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602293340906"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.19.9.920"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1053\/meta.2001.24192"},{"key":"e_1_2_6_27_2","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/00002030-199905280-00023","article-title":"Effects of metformin on insulin resistance and central adiposity in patients receiving effective protease inhibitor therapy","volume":"13","author":"Saint\u2010Marc T","year":"1999","journal-title":"AIDS"},{"key":"e_1_2_6_28_2","unstructured":"US Department of Health and Human Services.Guidelines for the Use of Antiretroviral Agents in HIV\u20101\u2010Infected Adults and Adolescents.http:\/\/www.aidsinfo.nih.gov\/guidelines\/September 2006."},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020709"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328011220e"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2007.00488.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2007.00488.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T03:45:19Z","timestamp":1696909519000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2007.00488.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,23]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1111\/j.1468-1293.2007.00488.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2007.00488.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,23]]}}}